1. Home
  2. BGDE vs IGC Comparison

BGDE vs IGC Comparison

Compare BGDE & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Big Digital Energy Inc. Common Stock

BGDE

Big Digital Energy Inc. Common Stock

N/A

Current Price

$5.39

Market Cap

31.5M

Sector

Finance

ML Signal

N/A

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.26

Market Cap

27.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGDE
IGC
Founded
N/A
2005
Country
Australia
United States
Employees
33
70
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
27.7M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
BGDE
IGC
Price
$5.39
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.25
AVG Volume (30 Days)
101.8K
361.7K
Earning Date
N/A
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.09
EPS
N/A
N/A
Revenue
N/A
$1,271,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.00
$0.24
52 Week High
$11.69
$0.50

Technical Indicators

Market Signals
Indicator
BGDE
IGC
Relative Strength Index (RSI) 24.21 47.03
Support Level $5.00 $0.25
Resistance Level $6.65 $0.31
Average True Range (ATR) 0.84 0.01
MACD -0.03 0.00
Stochastic Oscillator 17.45 35.21

Price Performance

Historical Comparison
BGDE
IGC

About BGDE Big Digital Energy Inc. Common Stock

Big Digital Energy Inc, formerly Mawson Infrastructure Group Inc is focused on digital infrastructure platforms. It designs, builds and operates next-generation digital infrastructure platforms for enterprise customers and for its own purposes. The company provides services spanning AI, HPC, digital assets including Bitcoin mining, and other intensive compute applications. The company delivers both self-mining operations and colocation services to enterprise customers with a vertically integrated infrastructure model built for scalability and efficiency. The company also has an energy management business, which utilizes software and analysis, to generate revenue by participating in energy management programs. It operates as one energy management and digital asset mining segment.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: